- Donate
- Understanding Rare Disease
- Living with a Rare Disease
- Community Support
- Advancing Research
- Driving Policy
- Get Involved
- Rare Disease News
- Resource Library
- About Us
- For Clinicians & Researchers
- For Patient Organizations
Janet Woodcock, MD served as Acting Commissioner of the US Food and Drug Administration from January 2021 to February 2022 and as Principal Deputy Commissioner from February 2022 to February 2024. Prior to that time, she served as Director of FDA’s Center for Drug Evaluation and Research (CDER).
One in 10 Americans lives with rare disease, many of whom fight a daily battle to access the care and support they need. Your gift to the National Organization for Rare Disorders (NORD®) funds life-changing programs and helps us advance policies and research to ensure that everyone gets the care they need AND deserve.